Suppr超能文献

免疫组织化学和颈动脉副神经节瘤中基因突变分析。

Immunohistochemistry and Mutation Analysis of Genes in Carotid Paragangliomas.

机构信息

Center for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, 119991 Moscow, Russia.

Vishnevsky Institute of Surgery, Ministry of Health of the Russian Federation, 117997 Moscow, Russia.

出版信息

Int J Mol Sci. 2020 Sep 22;21(18):6950. doi: 10.3390/ijms21186950.

Abstract

Carotid paragangliomas (CPGLs) are rare neuroendocrine tumors often associated with mutations in genes. The immunohistochemistry of succinate dehydrogenase (SDH) subunits has been considered a useful instrument for the prediction of mutations in paragangliomas/pheochromocytomas. We compared the mutation status of genes with the immunohistochemical (IHC) staining of SDH subunits in CPGLs. To identify pathogenic/likely pathogenic variants in genes, exome sequencing data analysis among 42 CPGL patients was performed. IHC staining of SDH subunits was carried out for all CPGLs studied. We encountered variants in 38% (16/42) of the cases in genes. IHC showed negative (5/15) or weak diffuse (10/15) SDHB staining in most tumors with variants in any of (94%, 15/16). In -mutated CPGL, SDHA expression was completely absent and weak diffuse SDHB staining was detected. Positive immunoreactivity for all SDH subunits was found in one case with a variant in . Notably, CPGL samples without variants in also demonstrated negative (2/11) or weak diffuse (9/11) SDHB staining (42%, 11/26). Obtained results indicate that SDH immunohistochemistry does not fully reflect the presence of mutations in the genes; diagnostic effectiveness of this method was 71%. However, given the high sensitivity of SDHB immunohistochemistry, it could be used for initial identifications of patients potentially carrying mutations for recommendation of genetic testing.

摘要

颈动脉体副神经节瘤(CPGL)是一种罕见的神经内分泌肿瘤,常与 基因突变有关。琥珀酸脱氢酶(SDH)亚单位的免疫组织化学已被认为是预测副神经节瘤/嗜铬细胞瘤 基因突变的有用工具。我们比较了 CPGL 中 基因突变状态与 SDH 亚单位的免疫组织化学(IHC)染色。为了鉴定 基因中的致病变异/可能致病变异,对 42 例 CPGL 患者的外显子组测序数据进行了分析。对所有研究的 CPGL 进行了 SDH 亚单位的 IHC 染色。在 基因中,我们在 38%(16/42)的病例中发现了 变异。IHC 显示在任何 基因的变异中(94%,15/16),大多数肿瘤的 SDHB 染色呈阴性(5/15)或弱弥漫性(10/15)。在 - 突变的 CPGL 中,SDHA 表达完全缺失,检测到弱弥漫性 SDHB 染色。在一个有 基因变异的病例中发现所有 SDH 亚单位的阳性免疫反应。值得注意的是,在没有 基因变异的 CPGL 样本中也发现了阴性(2/11)或弱弥漫性(9/11)SDHB 染色(42%,11/26)。研究结果表明,SDH 免疫组织化学不能完全反映 基因突变的存在;该方法的诊断有效性为 71%。然而,鉴于 SDHB 免疫组织化学的高灵敏度,它可以用于初步识别可能携带 基因突变的患者,建议进行基因检测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ba7/7576476/7e512012978f/ijms-21-06950-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验